Tag: nilesh gupta

Lupin appoints Christoph Funke as Chief Technical Operations Officer

Global pharma major Lupin Limited (Lupin) announced the appointment of Christoph Funke to the newly-created position of Chief Technical Operations Officer. With over 30 years of global pharmaceutical manufacturing, supply chain, and technical operations experience, Christoph brings a wealth of expertise to Lupin. He will be based in Mumbai and will oversee Lupin’s Technical Operations…

Lupin appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer

Global pharma major Lupin Limited (Lupin) announced the appointment of Dr. Shahin Fesharaki as Global Chief Scientific Officer. Dr. Fesharaki will be responsible for Lupin’s global research and development efforts across branded, generics and specialty products, a statement said. Commenting on the appointment, Vinita Gupta, CEO and Nilesh Gupta, MD, Lupin said, “We are very…

3i Infotech’s subsidiary makes strategic investments in Exium

3i Infotech Inc., USA, a step-down subsidiary of Mumbai-headquartered 3i Infotech Limited, a global Information Technology company, has announced a strategic investment in Exium, a pioneer in 5G powered Secure Access Services Edge (SASE) solutions, to help accelerate innovation in cloud-delivered security and digital experience. 3i Infotech will offer this as a premium security offering…

Lupin completes acquisition of brands from Anglo-French

Global pharma major Lupin Limited (Lupin) announced the completion of the acquisition of a portfolio of brands from Anglo-French Drugs & Industries Limited (AFDIL) and its Associates. The acquisition will strengthen Lupin’s India Formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products. The acquisition of the AFDIL brands takes Lupin…

Lupin’s Vizag API facility receives EIR from US FDA

Lupin Limited, an innovation-led transnational pharmaceutical company headquartered in Mumbai, announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) after closure of the inspection for its Vizag facility. The inspection for the API facility was conducted by the U.S. FDA between January 13, 2020 and…

Lupin pledges Rs21 cr towards COVID-19 relief efforts

The Coronavirus pandemic and the concern related to the extent of damage it can cause had brought in a good degree of participation form major corporations, philanthropists, and business leaders to support the fight against the pandemic. Pharma major Lupin Limited (Lupin) announced a contribution of Rs 21 crores for relief efforts directed towards mitigating…

Lupin Pharmaceuticals next-generation takes over the reins – Vinita Gupta, & Nilesh D Gupta

Lupin board of directors has approved the appointment of Vinita Gupta as Chief Executive Officer and Nilesh D. Gupta as Managing Director from September 2013.  Vinita and Nilesh are children of Dr. Desh Bandhu Gupta, Lupin’s Founder and Chairman. Kamal K. Sharma, present the company’s Managing Director would move up as Vice-Chairman. Vinita Gupta, has…